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Objective: Chordal cutting targeting leaflet tethering has been
described to improve the efficiency of annuloplasty during ischemic mitral
regurgitation surgery. Histotripsy is an ultrasound based technique for
tissue fragmentation through the cavitation generated by a very intense
ultrasonic pulse. In this study we investigate the feasibility of using histo-
tripsy for chordal cutting to avoid cardiopulmonary bypass and invasive
surgery in infarcted heart.
Methods: Experiments were performed in vitro in explanted sheep
heart (N=10) and in vivo in sheep beating heart (N=5, 40+/-4kg). In vitro,
the mitral valve basal chordae was removed, fixed on a holder in a water
tank. The ultrasound pulses were emitted from the therapeutic device (1-
MHz focused transducer, pulses of 8μs duration, peak negative pressure of
17 MPa, repetition frequency of 100Hz) placed at a distance of 64mm. In
vivo, we performed sternotomy and the device was applied on the thorax
cavity which was filled out with water. We analysed MV coaptation and
chordae by real time 3D echocardiography. The animals were sacrificed at
the end of the procedure, for postmortem anatomical exploration of the
heart.
Results: In vitro, all the basal chordae were completely cut. The mean pro-
cedure time was 5.5 (+/-1.7) minutes. The diameter of the chordae was the
main criteria affecting the duration of procedure. In the sheep, central basal
chordae of anterior leaflet were completely cut. The mean procedure time was
22 (+/-9) minutes. By echography, the sectioned chordae was visible and no
mitral valve prolapse was found. All the postmortem anatomical exploration
of hearts confirmed the section of the basal chordea. No additional lesions
were objectified.
Conclusions: Noninvasive ultrasound histotripsy succeed to cut mitral
valve basal chordae in vitro and in vivo in beating heart. If positive, this will
open the door of completely noninvasive technique for MV repair especially
in case of ischemic or functional MR.
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Purpose: The logistic Euroscore (Euroscore I) has been shown to lack
accuracy when applied to contemporary patients. The Euroscore II has there-
fore been recently proposed to improve the prediction of operative mortality,
but external validations are scarce. We compared the predictive performances
of the Euroscore I and II in our institution.
Methods: The Euroscore I and II were was computed in 5114 consecutive
patients who underwent cardiac surgery over a 5-year period. Discrimination
was assessed using the c-index and calibration by comparing predicted and
observed mortality. Besides the overall population we also specifically studied
elderly patients (age ≥80) and patients with a body mass index (BMI) <25.
Results: Mean age was 63±14 years. Mean Euroscore I was 6.8±8.7%,
mean Euroscore II 4.6±6.7% and 30-day mortality 4.8% (245 patients). C-
index and comparisons between predicted and observed mortality are detailed
in Table 1 for the overall population and for subgroups according to age and
BMI.
Conclusion: Euroscore II has indeed a better predictive performance than
the Euroscore I. Its discrimination and calibration are however less satisfying
in patients with BMI<25 or aged ≥80. BMI should thus be taken into account,
and in the elderly, other variables such as frailty may help to estimate more
accurately surgical risk.
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Purpose: Concerns have been raised regarding the reliability of the logistic
Euroscore (Euroscore I). The Euroscore II has been recently described to
achieve a more accurate prediction of operative mortality. However its perfor-
mance has not been specifically studied in valvular surgery.
Methods: The predictive performance of the Euroscore I and II was com-
pared in 2931 consecutive patients who underwent valvular surgery in our
institution between 2006 and 2010. Discrimination was assessed using the c-
index and calibration by comparing predicted and observed mortality.
Results: Mean age was 64±16 years, mean Euroscore I 8.8±9.9% and
mean Euroscore II 5.9±7.5%. Half of the patients underwent more than a
single valve procedure. Mortality at 30 days was 5.5% (160 patients). C-index
was 0.77 (95% CI 0.74-0.81) for the Euroscore I and 0.81 (95% CI 0.77-0.84)
for the Euroscore II. The overall comparison between predicted and observed
mortality showed a significant difference for the Euroscore I (p<0.0001),
whereas no difference was found for the Euroscore II (p=0.33). The Euroscore
I overestimated operative mortality, in particular in patients at intermediate
and high risk for surgery (Figure).
Conclusion: The Euroscore II achieves a good predictive performance in
the estimation of 30-day mortality after valvular surgery. Calibration is mark-
edly improved as compared with the Euroscore I. These results support the use
of the Euroscore II for valvular surgery.
Abstract 0029-Figure: Calibration plot for the Euroscore I and II
Abstract 0028-Table: Predictive properties of the Euroscore I and II
Overall 
population
Age< 80 Age≥80 BMI<25 BMI≥25
c-index Euroscore I 0.75 0,77 0,60 0,75 0,80
c-index Euroscore II 0,80 0,81 0,66 0,78 0,83
p (calibration) Euroscore I <0,001 0,001 <0,0001 0,007 <0,0001
p (calibration) Euroscore II 0,38 0,39 0,12 0,04 0,73
